Denise Ranucci, MD
Gynecology · Horsham, PANPI 1043338700
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,642 of the $2,415 with a category attached, or 68.0%. It is spread thinly across 21 manufacturers, the largest accounting for just 23.8%. Reporting peaked in 2021 at $968 and has fallen 90.3% since, to $94 in 2025.
Across 95 payments — averaging $25.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innocoll Pharmaceuticals Limited$575
- AbbVie$425
- Therapeuticsmd, Inc.$271
- Mayne Pharma Commercial LLC$237
- Astellas Pharma US Inc$186
- Millicent US Inc$98
- plus $622 from 15 others
What the payments were for
- Consulting fees$57524%
- Food & beverage$1,64268%
- Education$1988%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innocoll Pharmaceuticals Limited | 1 | $575 |
| AbbVie(2 entities) | 22 | $425 |
| Therapeuticsmd, Inc. | 15 | $271 |
| Mayne Pharma Commercial LLC | 12 | $237 |
| Astellas Pharma US Inc | 4 | $186 |
| Millicent US Inc | 5 | $98 |
| Coopersurgical, Inc. | 6 | $93 |
| Myovant Sciences Inc. | 5 | $86 |
| Avion Pharmaceuticals | 5 | $80 |
| Boston Scientific | 4 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Merck | 2 | $37 |
| Urovant Sciences Inc | 1 | $34 |
| Mylan Pharmaceuticals Inc. | 1 | $26 |
| Pfizer | 2 | $25 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Amgen | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Dysis Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARACOLL$575
How this compares
$2,415 in reported general payments places this provider in the 75th percentile of 98 gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 23 | $18,326 |
| EstringEstradiol | 15 | $7,949 |
| PremarinEstrogens, Conjugated | 14 | $6,199 |
| Estradiol | 89 | $6,193 |
| Clobetasol Propionate | 20 | $453 |
| Alendronate Sodium | 39 | $277 |
| Ibandronate Sodium | 11 | $230 |
| Triamcinolone Acetonide | 18 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $186 | $18,32623 claims |
| PfizerEstring, Premarin | $25 | $14,14829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 98 gynecology providers in Pennsylvania.
Other gynecology in Horsham
- Anthony MatteoHorsham$1K
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Harold DavisScranton$22K
- Reneita RossPhiladelphia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.